Hi All due to it proving impossible to reach a consensus on suggestions, I’m continuing this list with the intention of it only being a list of suggestions that the US orgs can consider if they want. If anyone would like to contribute please read this post 452 http://forums.phoenixrising.me/index.php?threads/now-that-cfsacs-over-what-should-we-do.17972/page-23 first
List of ideas for the US ME/CFS orgs.
1a. The CFSAC will be asked to recommend to the secretary of the HHS that the CDC CFS department is closed permanently, and its CFS website taken down, and all research that it is presently conducting to be stopped, and that the HHS will set up a new CFS department in another one of its agencies (such as the NIH) and that all government funding that the CDC has been receiving will be transferred to this new CFS department. If more funding is needed to achieve articles 2 and 3 of these recommendations the HHS will insure that they are provided. The HHS will supervise the creation of this new CFS department and insure that highly trained staff are selected for it and that it conducts itself in a highly scientific manner and is dedicated to finding the answers to the scientific nature of this condition and finding treatments to end the suffers pain
1b. This new CFS department will be instructed that as correct scientific procedure has never been followed in the history of this illness and replication studies have not been done to ascertain the true cause, CFS will be viewed until such time as the science has been done, as a disease of unknown cause, and it will be assumed that it is a physical illness until such time as this science has been done, (due to the detrimental effect on the patients of the previous assumed psychiatric nature of this illness) The new website created by the agency that has been assigned CFS will not contain any information that states or implies that CFS is a psychiatric illness, and will not recommend psychiatric treatments such as GET and CBT due to evidence that they may have a detrimental effect on some patients physical health.
(The new agency that sets up the new CFS department will be instructed that its number one priorities are to fix the massive problems of not having a complete differential and testing guide to rule out all other diseases that can cause the symptoms attributed to ME/CFS, and to immediately start fixing a almost complete lack of replicated science in this field. They will be instructed to do these things)
2a. An independent panel of Diagnostic experts will be created to write a complete differential diagnosis list and testing guide to rule out all other diseases that can cause the symptoms attributed to ME/CFS. They will write a step by step easy to follow guide on how to rule out all the other diseases and all the tests that are needed to do this. For difficult to diagnoses diseases, and where newer information for diagnosing certain diseases has been discovered that doctors may not be aware of. This guide will provide instructions on this and/or references to the relevant information Clinicians and researchers who have already created differential diagnoses lists that are more comprehensive then the CDCs list, or have a track record in finding the misdiagnosed patients in the CFS group, will be consulted or included in the panel. Such as Dr Byron Hyde, Dr Shirwan A Mirza, the writers of the CCC, and the writers of the IACFS/ME toolkit etc.
2b. When this new differential and testing guide is created it will be placed prominently on the new website created by the agency that has been entrusted with the new CFS department. Where it will be freely available to the medical community and patients.
2c.The HHS will inform the medical community and insurance companies of the existence of this new Differential and testing guide and recommend that it is used to rule out all other known disease that can cause the symptoms attributed to ME/CFS in all patients suspected of having ME/CFS. And all already diagnosed ME/CFS patients who have not had the testing recommended in the newly created guide.
3a. A new definition/definitions will be created, that will be based on independently replicated science. This replicated science will be based on the patients having had all the testing to rule out all other diseases that cause the symptoms attributed to ME/CFS, using the differential diagnosis and testing guide that will have been created when article 2a has been accomplished.
(This is to insure that people with other undiagnosed known illnesses are not included in the research, because it will have a detrimental effect on the results of the replication study)
A review of the medical literature will be done, to compile a list of the physical anomalies that have been found in CFS and ME patients, such as SPECT, PET, MRI scans, NK cells, RNase L, VO2 max, POTs, NMH etc, etc. Tests for the physical anomalies that are found in the review of the medical literature will be performed in a replicated manner on all the patients in all the groups selected for this replication study.
3b From this scientific information a new definition/definitions will be written. And new name/names for the illness/illnesses will then be created based on the scientific findings. CFS will not be used as the name for any of the illness/illnesses that have been defined.
(Due to the strong dislike amongst the patient community for this name, its failure to accurately define the symptoms the patient’s experience and its long history of being portrayed as a psychiatric illness)
3c. The Patient Community will be regularly updated on the progress of this project and the details of it, this information will be made available to the patient community via the new website that is created by the new CFS department
3d. Adequate Funding will then be provided to further research patients that fit the definition/definitions created by this process to find diagnostic tests, causes and treatments.
More information that explains the need for article 1, and supporting information and actions to achieve steps 1, 2, and 3 can be found in post. #454 http://forums.phoenixrising.me/index.php?threads/now-that-cfsacs-over-what-should-we-do.17972/page-23
More information that explains the details of and the need for article 2 can be found in post #421 here http://forums.phoenixrising.me/index.php?threads/now-that-cfsacs-over-what-should-we-do.17972/page-22 And post #168 http://forums.phoenixrising.me/index.php?threads/now-that-cfsacs-over-what-should-we-do.17972/page-9
Detailed information on the need for replicated science can be found in Corts article here http://forums.phoenixrising.me/index.php?threads/once-is-not-enough-by-simon-mcgrath.18191/
A more detailed explanation of the replication study proposed in 3 can be found in Post #331 http://forums.phoenixrising.me/index.php?threads/now-that-cfsacs-over-what-should-we-do.17972/page-17
I would also like to suggest that if the proposal to meet with the Secretary of the HHS Kathleen Sebelius is accepted that this plan is given directly to her as well as going through the CFSAC see http://forums.phoenixrising.me/index.php?threads/me-cfs-orgs-push-secretary-of-health-sibelius-for-strategy-meeting.18237/
Other suggestions made are
Alternatives 4:
4i. That, consistent with its statement that “ME is accompanied by neurologic and muscular signs and has a case definition distinct from that of CFS,” the CDC will recognize the ME-ICC and its predecessor, the Canadian Consensus Criteria, as case definitions for ME, distinguishing ME (ICC, CCC) from CFS (Reeves, Fukuda).
Research on the ME/CFS population should not be carried out with the assumption that the cohort represents a homogeneous population.
4iii. That, consistent with its statement that “ME is accompanied by neurologic and muscular signs and has a case definition distinct from that of CFS,” the CDC should recognize the ME-ICC, as the case definition for ME, until such time as (articles 2a and 2b have been completed and) a new definition has been written based on replicated science. Until then ME-ICC will be used to distinguish ME from CFS (Reeves, Fukuda).
Research on the ME/CFS population should not be carried out with the assumption that the cohort represents a homogeneous population.
5. More research funding for the biomedical model of illness, using CCC and ICC alongside Fukuda for all research, until such time as the new definition based on replicated science is completed.
Research on the ME/CFS population should not be carried out with the assumption that the cohort represents a homogeneous population.
Alternatives 5:
5i. More research funding for the biomedical model of illness, using CCC and ICC for all research, until such time as a new definition based on replicated science is created.
Research on the ME/CFS population should not be carried out with the assumption that the cohort represents a homogeneous population.
6. Promotion of CBT and GET as therapies for CFS patients will be removed from CDC literature, toolkit and website.
(
can we be specific about what we want removed?)
Alternatives 6:
6ii. The CDC to remove all reference to CBT and GET from it's website, and clinicians warned that these therapies do not help the majority of CFS/ME patients, and a high proportion of patients anecdotally report being harmed.
The PACE Trial* demonstrated that CBT is ineffective at reducing phsycial disability in secondary care patients.
The PACE Trial demonstrated that only approximately 13% of secondary care patients respond to CBT or GET, but the trial excluded severely affected patients.
The FINE Trial* demonstrated that severely affected patients do not respond to therapies based on CBT that include components of GET.
In UK patient organisation surveys*, a high proportion of respondent reported being harmed by both CBT and GET,
7. The CDC will remove all information from their website based on CF/idiopathic fatigue (Oxford and 'Empirical' studies) or meta-analyses and review articles conflating CF/idiopathic fatigue with ME/CFS.
(should we be more specific about this and provide specific information about what we want removing, or at least examples?)
Alternatives 7:
7i. "The CDC will remove all information from the CDC's CFS website, CDC's CFS literature, & CFS toolkit, that is based on CF/idiopathic fatigue (Oxford and 'Empirical' studies) or meta-analyses and review articles conflating CF/idiopathic fatigue with ME/CFS."
7ii. The CDC will conduct a systematic review of all its past research, and removed from the CDC's CFS website, CDC's CFS literature, & CFS toolkit, any information and research that is based on on CF/idiopathic fatigue (Oxford and 'Empirical' studies) or meta-analyses and review articles conflating CF/idiopathic fatigue with ME/CFS. Any unretracted or unremoved research, which is based on the previously described criteria, must be clearly marked as outdated.
7iii. The CDC will remove all information from the CDC's CFS website, CDC's CFS literature, & CFS toolkit, that is based on CF/idiopathic fatigue (Oxford and 'Empirical' studies) or meta-analyses and review articles conflating CF/idiopathic fatigue with ME/CFS.
8. The CFSAC should review all their previous recommendations for clarity, utility, redundancy, and applicability. Based on this review, and a review of responses received from the Assistant Secretary and Secretary (if any), and the requests we outline, the CFSAC should re-issue.
Alternatives 8:
8i. The CFSAC should review all their previous recommendations for clarity, utility, redundancy, and applicability. Based on this review, and a review of responses received from the Assistant Secretary and Secretary (if any), the CFSAC should re-issue recommendations that address current priorities in ME/CFS policy in a clear and concise manner.
8ii. The CFSAC should review all their previous recommendations for clarity, utility, redundancy, and applicability. Based on this review, and a review of responses received from the Assistant Secretary and Secretary (if any), and the requests we outline, the CFSAC should re-issue recommendations that address current priorities in ME/CFS policy in a clear and concise manner.
9. The CDC will produce a state-of-knowledge article, updated annually, in relation to ME/CFS, so that the older research and current views can be put in perspective. This will be an annual review article to be published.
10. The CFSAC should aim to educate physicians, schools, social services, and the public through any means possible to it, including making recommendations.
(The reference to eduction has been placed back on the list, but with different wording - whoever first opposed the original item re eduction, please can you repost you objection if still appropriate.)
11. CDC should cease use of the surveys developed and presented in its "clinically empirical approach to the definition and study" of the disease, Reeves et al. 2005.
(Again, this has been reposted but with different wording. If the original objections still apply, then please repost them.)
Alternative 11:
11i. CDC should cease diagnostic use of the surveys in its "clinically empirical approach to the definition and study" of the disease, Reeves et al. 2005,